Crystal Rock Capital Management’s Allergan plc AGN Stock Holding History

Crystal Rock Capital Management’s Portfolio AGN Stock Details AGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-7,061	Closed	-$1.35M	–	38
2019 Q4	$1.35M	Sell	7,061 -3,450	-33%	-$622K	0.88%	30
2019 Q3	$1.77M	Hold	10,511	–	–	1.3%	27
2019 Q2	$1.76M	Sell	10,511 -11,275	-52%	-$1.56M	1.3%	24
2019 Q1	$3.19M	Hold	21,786	–	–	2.36%	21
2018 Q4	$2.91M	Sell	21,786 -1,850	-8%	-$303K	2.61%	19
2018 Q3	$4.5M	Sell	23,636 -675	-3%	-$124K	3.1%	13
2018 Q2	$4.05M	Buy	24,311 +4,850	+25%	+$779K	2.89%	15
2018 Q1	$3.27M	Hold	19,461	–	–	2.29%	18
2017 Q4	$3.18M	Sell	19,461 -1,470	-7%	-$264K	2.05%	19
2017 Q3	$4.29M	Sell	20,931 -1,200	-5%	-$279K	2.86%	15
2017 Q2	$5.38M	Hold	22,131	–	–	3.48%	13
2017 Q1	$5.29M	Buy	22,131 +4,311	+24%	+$1M	3.38%	13
2016 Q4	$3.74M	Buy	+17,820	New	+$3.69M	2.46%	17

Other funds holding AGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Crystal Rock Capital Management's AGN Position: Q1 2020 in Review

Crystal Rock Capital Management sold out of Allergan plc (AGN) in Q1 2020, closing a stake of 7,061 shares — an estimated $1.35M sold.

Crystal Rock Capital Management first reported a position in AGN in Q4 2016 and held it in 13 quarters. The position peaked at $5.38M in Q2 2017. 876 funds tracked by Wall St. Rank hold AGN as of Q1 2020.

Crystal Rock Capital Management reported no remaining Allergan plc position as of Q1 2020 after selling out during the quarter.
Crystal Rock Capital Management sold 7,061 Allergan plc shares in Q1 2020, an estimated $1.35M.
Crystal Rock Capital Management first reported a position in Allergan plc in Q4 2016 and held it in 13 quarters.
Crystal Rock Capital Management's Allergan plc position peaked at $5.38M in Q2 2017.
876 funds tracked by Wall St. Rank held Allergan plc as of Q1 2020.

Based on Crystal Rock Capital Management's 13F filing for Q1 2020, filed 8 May 2020.